Literature DB >> 18778365

Impaired immune responses in streptozotocin-induced type I diabetes in mice. Involvement of high glucose.

R Rubinstein1, A M Genaro, A Motta, G Cremaschi, M R Wald.   

Abstract

Diabetes is widely believed to predispose to serious infections. However, the mechanisms linking diabetes and immunosuppression are not well defined. One potential mediator of the altered defence mechanisms is hyperglycaemia. It has been identified as the main factor contributing to the development of diseases associated with diabetes mellitus. In this study we analyse the immune response in diabetes and the direct effect of hyperglycaemia on T and B lymphocyte reactivity. Diabetes induced an early decrease in IgG levels in the secondary response. However, both primary responses against a T-cell-dependent or independent antigen were affected after 6 months of diabetes induction. T- and B- cell proliferation was only decreased at this time. To gain insight into the potential mechanisms involved, we evaluated the influence of hyperglycaemia over the immune response. Pre-incubation of lymph node and spleen cells in a high glucose (HG) containing medium led to a significant time- and dose-dependent decrease in T- and B-cell proliferation. This effect was associated with the presence of HG-derived supernatants. Still viable cells after HG exposition were able to improve their proliferative response when cultured with the mitogen in a fresh standard medium. HG diminished cell viability, increased apoptosis and induced oxidative stress in lymphocytes. These results indicate that HG concentrations can directly affect lymphoid cell growth. An increase in oxidative stress would be implicated in this deleterious effect. The possibility that prolonged exposure to pathologically HG concentrations would result in the immunosuppressive state observed in diabetes is also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18778365      PMCID: PMC2612711          DOI: 10.1111/j.1365-2249.2008.03742.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  75 in total

Review 1.  Infections in patients with diabetes mellitus.

Authors:  N Joshi; G M Caputo; M R Weitekamp; A W Karchmer
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

Review 2.  Glutathione deficiency and human immunodeficiency virus infection.

Authors:  F J Staal; S W Ela; M Roederer; M T Anderson; L A Herzenberg; L A Herzenberg
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

Review 3.  Role of advanced glycosylation products in complications of diabetes.

Authors:  A Cerami; H Vlassara; M Brownlee
Journal:  Diabetes Care       Date:  1988 Nov-Dec       Impact factor: 19.112

4.  Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species.

Authors:  X L Du; G Z Sui; K Stockklauser-Färber; J Weiss; S Zink; B Schwippert; Q X Wu; D Tschöpe; P Rösen
Journal:  Diabetologia       Date:  1998-03       Impact factor: 10.122

5.  High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3.

Authors:  F M Ho; S H Liu; C S Liau; P J Huang; S Y Lin-Shiau
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

Review 6.  Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-03-11

7.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

8.  The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.

Authors:  D L Hamilos; H J Wedner
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo.

Authors:  Bernhard Moser; Dharmesh D Desai; Matthew P Downie; Yali Chen; Shi Fang Yan; Kevan Herold; Ann Marie Schmidt; Raphael Clynes
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

Review 10.  Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?

Authors:  Joseph L Evans; Ira D Goldfine; Betty A Maddux; Gerold M Grodsky
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

View more
  21 in total

1.  Experimental diabetes attenuates calcium mobilization and proliferative response in splenic lymphocytes from mice.

Authors:  Eiki Satoh; Ryota Iwasaki
Journal:  J Physiol Sci       Date:  2010-10-23       Impact factor: 2.781

2.  Metabolic and clinical effects of the supplementation of a functional mixture of amino acids in cerebral hemorrhage.

Authors:  Alessandro Laviano; Flavia Aghilone; Donato Colagiovanni; Federica Fiandra; Roberta Giambarresi; Paolo Tordiglione; Alessio Molfino; Maurizio Muscaritoli; Giovanni Rosa; Filippo Rossi Fanelli
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

3.  Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice.

Authors:  Ian Y Zhang; Hui Zhou; Huili Liu; Leying Zhang; Hang Gao; Shunan Liu; Yanyan Song; Darya Alizadeh; Hongwei Holly Yin; Raju Pillai; Behnam Badie
Journal:  Clin Cancer Res       Date:  2020-02-04       Impact factor: 12.531

4.  Decreased cystathionine-γ-lyase (CSE) activity in livers of type 1 diabetic rats and peripheral blood mononuclear cells (PBMC) of type 1 diabetic patients.

Authors:  Prasenjit Manna; Neslihan Gungor; Robert McVie; Sushil K Jain
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

5.  Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes.

Authors:  Joseph Pidala; Jongphil Kim; Mohamed A Kharfan-Dabaja; Taiga Nishihori; Teresa Field; Janelle Perkins; Lia Perez; Hugo Fernandez; Claudio Anasetti
Journal:  Biol Blood Marrow Transplant       Date:  2010-07-15       Impact factor: 5.742

6.  Differential effect of hyperglycaemia on the immune response in an experimental model of diabetes in BALB/cByJ and C57Bl/6J mice: participation of oxidative stress.

Authors:  M R Rubinstein; A M Genaro; M R Wald
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

7.  Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes.

Authors:  Sushil K Jain; David Micinski
Journal:  Biochem Biophys Res Commun       Date:  2013-06-11       Impact factor: 3.575

8.  Glucose impairs B-1 cell function in diabetes.

Authors:  K Jennbacken; S Ståhlman; L Grahnemo; O Wiklund; L Fogelstrand
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

9.  Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.

Authors:  K C Herold; S E Gitelman; S M Willi; P A Gottlieb; F Waldron-Lynch; L Devine; J Sherr; S M Rosenthal; S Adi; M Y Jalaludin; A W Michels; J Dziura; J A Bluestone
Journal:  Diabetologia       Date:  2012-10-21       Impact factor: 10.122

10.  Lactoferrin and Immunoglobulin Concentrations in Milk of Gestational Diabetic Mothers.

Authors:  Jolanta Lis-Kuberka; Marta Berghausen-Mazur; Magdalena Orczyk-Pawiłowicz
Journal:  Nutrients       Date:  2021-03-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.